As of January 22, 2025, Benitec Biopharma (BNTC) has a market cap of $0.25 billion USD. According to our data, Benitec Biopharma is ranked No.6885 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.25 B |
-15.36%
|
Dec 31, 2024 | $0.29 B |
291.02%
|
Dec 29, 2023 | $74.99 M |
11.76%
|
Dec 30, 2022 | $67.10 M |
-93.51%
|
Dec 31, 2021 | $1.03 B |
-12.67%
|
Dec 31, 2020 | $1.18 B |
-60.78%
|
Dec 31, 2019 | $3.02 B |
-66.00%
|
Dec 31, 2018 | $8.88 B |
-49.27%
|
Dec 29, 2017 | $17.50 B |
93.46%
|
Dec 30, 2016 | $9.05 B |
-61.94%
|
Dec 31, 2015 | $23.77 B |
-74.16%
|
Dec 31, 2014 | $92.01 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Arrowhead Pharmaceuticals
ARWR
|
$2.45 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Market Cap | = | BNTC Stock Price | * | BNTC Shares Outstanding |
= | $10.69 | * | 23.22 M | |
= | $0.25 B |